Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies

Medical Electron Microscopy

Volumn 37, Issue 2, 2004, Pages 114-118

  Pei, Ren Jeng ^a   Danbara, Naoyuki ^a   Tsujita Kyutoku, Miki ^a   Yuri, Takashi ^a   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokeratin; Immunohistochemistry; Mallory body; Ubiquitin

Indexed keywords

CYTOKERATIN; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 11; CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 15; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; CYTOKERATIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; KERATIN;

ANTIGENICITY; ARTICLE; AUTOPSY; CELL INCLUSION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALLORY BODY; PRIORITY JOURNAL; LIVER CELL; LIVER TUMOR; METABOLISM; PATHOLOGY;

CARCINOMA, HEPATOCELLULAR; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; KERATINS; LIVER DISEASES; LIVER NEOPLASMS;

EID: 3142685518     PISSN: 09184287     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00795-003-0240-1     Document Type: Article

References (33)

1. Jensen K, Gluud C (1994) The Mallory body: morphological, clinical and experimental studies (part 1 of a literature survey). Hepatology 20:1061-1077
2. Nayak NC, Sagreiya K, Ramalingaswami V (1969) Indian childhood cirrhosis. The nature and significance of cytoplasmic hyaline of hepatocytes. Arch Pathol Lab Med 88:631-637
3. Stromeyer FW, Ishak KG (1980) Histology of the liver in Wilson's disease: a study of 34 cases. Am J Clin Pathol 73:12-24
4. Portmann B, Popper H, Neuberger J, Williams R (1985) Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 88:1777-1790
5. Nakanuma Y, Ohta G (1986) Expression of Mallory bodies in hepatocellular carcinoma in man and its significance. Cancer (Phila) 57:81-86
6. Hoso M, Nakanuma Y (1990) Clinicopathological characteristics of hepatocellular carcinoma bearing Mallory bodies: an autopsy study. Liver 10:264-268
7. Mallory FB (1911) Cirrhosis of the liver: five different types of lesions from which it may arise. Bull Johns Hopkins Hosp 22:69-75
8. Denk H, Stumptner C, Zatloukal K (2000) Mallory bodies revisited. J Hepatol 32:689-702
9. Wiggers KD, French SW, French BA, Carr BN (1973) The ultrastructure of Mallory body filaments. Lab Invest 29:652-658
10. Katsuma Y, Swierenga SH, Khettry U, Marceau N, French SW (1987) Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Hepatology 7:1215-1223
11. Ohta M, Marceau N, Perry G, Manetto V, Gambetti P, Autilio-Gambetti L, Metuzals J, Kawahara H, Cadrin M, French SW (1988) Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest 59:848-856
12. Schirmacher P, Dienes HP, Moll R (1998) De novo expression of nonhepatocellular cytokeratins in Mallory body formation. Virchows Arch 432:143-152
13. Stumptner C, Fuchsbichler A, Heid H, Zatloukal K, Denk H (2002) Mallory body - a disease-associated type of sequestosome. Hepatology 35:1053-1062
14. Van Eyken P, Sciot R, Desmet VJ (1988) A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express "bile duct-type" cytokeratins. Histopathology (Oxf) 13:605-617
15. Savolainen VT, Lalu K, Penttila A, Virtanen I, Karhunen PJ (1994) Cytokeratin inclusions in alcoholic liver disease and their relation to the amount of alcohol intake. Liver 14:281-287
16. Ray MB (1987) Distribution patterns of cytokeratin antigen determinants in alcoholic and nonalcoholic liver diseases. Hum Pathol 18:61-66
17. Baptista A, Bianchi L, de Groote J, Desmet VJ, Gedigk P, Korb G, MacSween RNM, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Wepler W (1981) Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1:707-711
18. Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 155:9-15
19. Banner BF, Savas L, Zivny J, Tortorelli K, Bonkovsky HL (2000) Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis. Am J Clin Pathol 114:860-866
20. Denk H, Eckerstorfer R, Gschnait F, Konrad K, Wolff K (1976) Experimental induction of hepatocellular hyalin (Mallory bodies) in mice by griseofulvin treatment. 1. Light microscopic observation. Lab Invest 35:377-382
21. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24
22. van Eyken P, Sciot R, van Damme B, de Wolf-Peeters C, Desmet VJ (1987) Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol 412:63-72
23. Van Eyken P, Sciot R, Desmet VJ (1989) A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express "bile duct-type" cytokeratins. Histopathology (Oxf) 15:125-135
24. Preisegger KH, Zatloukal K, Spurej G, Denk H (1991) Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies. Liver 11:300-309
25. Matsumoto S, Yamamoto K, Nagano T, Okamoto R, lbuki N, Tagashira M, Tsuji T (1999) Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition. Liver 19:32-38
26. Yabushita K, Yamamoto K, Ibuki N, Okano N, Matsumura S, Okamoto R, Shimada N, Tsuji T (2001) Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis. Liver 21:50-55
27. Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, Blumgart LH, Jarnagin W, Ladanyi M, Klimstra DS (2002). Combined hepatocellular- cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol 26:989-997
28. Lai YS, Thung SN, Gerber MA, Chen ML, Schaffner F (1989) Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas. Arch Pathol Lab Med 113:134-138
29. Okanoue T, Ohta M, Ou O, Kachi K, Kagawa K, Yuki T, Okuno T, Takino T, French SW (1985) Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study. Lab Invest 53:534-540
30. Fleming KA, Morton JA, Barbatis C, Burns J, Canning S, McGee JO (1981) Mallory bodies in alcoholic and non-alcoholic liver disease contain a common antigenic determinant. Gut 22:341-344
31. Fukunaga N, Fujioka A, Tanaka K, Toyama R (1996) Oncocytic hepatocellular carcinoma with numerous globular hyaline bodies. Pathol Int 46:286-291
32. Nakashima O, Sugihara S, Eguchi A, Taguchi J, Watanabe J, Kojiro M (1992) Pathomorphologic study of pale bodies in hepatocellular carcinoma. Acta Pathol Jpn 42:414-418
33. Scheimberg I, Cullinane C, Kelsey A, Malone M (1996) Primary hepatic malignant tumor with rhabdoid features. A histological, immunocytochemical, and electron microscopic study of four cases and a review of the literature. Am J Surg Pathol 20:1394-1400